Xylem (XYL) EBT (2010 - 2026)

Xylem has reported EBT for 17 years, with the latest figure at $364.0 million in Q2 2026.

• On a quarterly basis, EBT rose 21.74% year-over-year to $364.0 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 9.74% increase from a year earlier, with the FY2025 full-year figure at $1.2 billion, up 8.65% from the prior year.
• EBT was $364.0 million for Q2 2026 at Xylem, up from $244.0 million in the prior quarter.
• The five-year high for EBT was $375.0 million in Q4 2024, with the low at $17.0 million in Q3 2022.
• Average EBT over 5 years is $219.5 million, with a median of $213.5 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EBT sank 87.22% in 2022, then soared 988.24% in 2023.
• Over 5 years, EBT stood at $189.0 million in 2022, then advanced by 11.11% to $210.0 million in 2023, then surged by 78.57% to $375.0 million in 2024, then dropped by 1.87% to $368.0 million in 2025, then declined by 1.09% to $364.0 million in 2026.
• The last three EBT figures came in at $364.0 million (Q2 2026), $244.0 million (Q1 2026), and $368.0 million (Q4 2025), per Business Quant data.